What is the current price and trading status of IGPH.SW stock?

IGPH.SW stock trades pre-market at **CHF 0.0015** on 25 Feb 2026, down **25.0%**, with volume at **2,033,000**. The large volume makes liquidity and execution risk higher than usual.

What grade does Meyka AI assign to IGPH.SW stock and why?

Meyka AI rates IGPH.SW with a score out of 100: **62.58 | Grade B | Suggestion: HOLD**. The grade factors sector comparison, financial growth, key metrics and analyst signals, and it is informational not investment advice.

What is Meyka AI’s near-term forecast for IGPH.SW stock?

Meyka AI's forecast model projects **CHF 0.0030**, implying about **+100.00%** from the current **CHF 0.0015**. Forecasts are model-based projections and not guarantees.

What are the main risks for investors in IGPH.SW stock?

Main risks include negative EPS, low current ratio (**0.19**), negative book value per share, and potential dilution from capital raises. These make IGPH.SW stock a high-risk holding for longer-term investors.

CH Stocks

CHF 0.0015 (-25%): IGEA Pharma IGPH.SW (SIX) pre-market 25 Feb, heavy volume

ByDanny Kontos February 25, 2026

We see IGEA Pharma N.V. (IGPH.SW) trade at CHF 0.0015 in the pre-market session on 25 Feb 2026, down 25.0% on the day with 2,033,000 shares changing hands. The spike in volume makes IGPH.SW stock one of the most active names on SIX this morning and raises liquidity and short-term risk questions. We outline the drivers: raw price action, market-cap structure, recent financials and a concise Meyka AI forecast to help frame potential next steps for traders and investors.